Abstract
Recent studies have demonstrated that there are differences among races in efficacy, tolerance and other outcomes in oncologic care. Some of these differences may be explained by different pharmacogenetics; however, social and environmental factors that can affect oncology practice are relatively underestimated. In this review we will focus on differences in environment, education and research between Japan and the US when it comes to lung cancer clinical practice. Such social differences seem to derive from historical reasons and continue to influence clinicians and researchers who manage lung cancer. Understanding the differences might help us conduct collaborative research in the future.
Original language | English (US) |
---|---|
Pages (from-to) | 3804-3808 |
Number of pages | 5 |
Journal | Journal of Thoracic Disease |
Volume | 12 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2020 |
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine